CytomX Therapeutics, Inc. ($CTMX)
BELVIN MARCIA โ SVP, Chief Scientific Officer
Shares
31,492
Price
$6.42
Total Value
$202,273.12
Nearby Earnings
Mar 5, 2026
EPS:Est: -0.08
Revenue:Est: $7.33M
Mar 16, 2026
EPS:-0.22 (est: -0.09)+135.7%
Revenue:$663.00K (est: $6.28M)-89.4%
Transaction Details
| Insider | BELVIN MARCIA |
|---|---|
| Title | SVP, Chief Scientific Officer |
| Transaction Date | Mar 17, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 19, 2026 |
| Shares Sold | 31,492 |
| Price per Share | $6.42 |
| Total Value | $202,273.12 |
| Shares Owned After | 300,760 |
| Derivative | No |
| Accession Number | 0001610717-26-000123 |
| Document | View SEC Filing |